Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 14, 2009; 15(18): 2177-2183
Published online May 14, 2009. doi: 10.3748/wjg.15.2177
Published online May 14, 2009. doi: 10.3748/wjg.15.2177
Type 1 | Type 2 | Type 3 | |
Percentage (%) | 70-85 | 5-10 | 15-25 |
Tumor characteristics | Often small, multiple, polypoid, multicentric | Often small, multiple, polypoid, multicentric | Single, > 1-2 cm, polypoid and often ulcerated |
Mean age at diagnosis (yr) | 63 | 50 | 55 |
Gender | Females > males | Females = males | Males > females |
Associated conditions | Chronic atrophic gastritis type A | ZES/MEN1 | Sporadic |
Serum gastrin levels | Increased | Increased | Normal |
pH of gastric juice | Increased | Low | Normal |
Ki-67 (%) | Usually < 2 | Usually < 2 | Usually > 2 |
Metastases (%) | 2-5 | < 10 | > 50 |
Well-differentiated tumor-carcinoid |
Benign behavior: confined to mucosa-submucosa, non-angioinvasive, ≤ 1 cm in size, non-functioning |
ECL cell tumor of corpus-fundus associated with hypergastrinemia and chronic atrophic gastritits (CAG) or MEN1 syndrome |
Serotonin-producing tumor |
Gastrin-producing tumor |
Uncertain behavior: confined to mucosa-submucosa, > 1 cm in size, or angioinvasive |
ECL cell tumor with CAG or MEN1 syndrome or sporadic |
Serotonin-producing tumor |
Gastrin-producing tumor |
Well-differentiated endocrine carcinoma-malignant carcinoid |
Low-grade malignant, deeply invasive (muscularis propria or beyond), or with metastasis |
Nonfunctioning |
ECL cell carcinoid, usually sporadic, rarely in CAG or MEN1 syndrome |
Serotonin-producing tumor |
Gastrin-producing tumor |
Functioning |
ECL cell carcinoid with atypical carcinoid syndrome |
Serotonin-producing carcinoid with syndrome |
Gastrin-producing carcinoma-malignant gastrinoma |
ACTH-producing carcinoma with Cushing syndrome |
Poorly differentiate endocrine carcinoma-small cell carcinoma, high grade malignant, usually non-functioning, occasionally with Cushing syndrome |
Primary tumor | ||||
Depth of invasion | Size | |||
T1 | Up to and including muscularis propria | ≤ 3 cm | ||
T2 | Beyond muscularis propria | ≤ 3 cm | ||
T3 | Up to and including muscularis propria | > 3 cm | ||
Beyond muscularis propria | > 3 cm | |||
Lymph node | ||||
N0 | No lymph node metastasis | |||
N1 | Regional lymph node metastasis | |||
Distant metastasis | ||||
M0 | No distant metastasis | |||
M1 | Distant metastasis | |||
Disease stage | T | N | M | |
I | T1 | Any N | M0 | |
II | T2 | N0 | M0 | |
T3 | N0 | M0 | ||
III | T2 | N1 | M0 | |
IV | T3 | N1 | M0 | |
Any T | Any N | M1 |
- Citation: Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009; 15(18): 2177-2183
- URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2177.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2177